{"id":"c6810b8a-034d-48b4-bde8-0698b25c1131","slug":"radiosurgery-vs-radiation","title":"Radiosurgery vs radiation therapy for brain metastases: A waning controversy","authors":["L. Dade Lunsford"],"abstract":"Background: Recent commentaries reflect ongoing discord regarding the treatment of brain metastases, particularly between the roles of stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT). The shift towards SRS has been influenced by its ability to improve quality of life and reduce neurocognitive dysfunction compared to WBRT, which has been traditionally used for decades. Summary: The evolution of brain metastases management has seen a transition from WBRT to SRS, driven by clinical trials and anecdotal evidence of better outcomes. While some experts advocate for the continued use of WBRT, others emphasize the benefits of SRS, including improved quality of life and lower toxicity. The debate continues, but there is a consensus that SRS effectively controls brain disease in a significant majority of patients. Conclusion: The ongoing discussion about the roles of SRS and WBRT in treating brain metastases highlights the need for a reevaluation of treatment paradigms. As cancer management evolves towards chronic disease models, maintaining both brain and systemic health is crucial. The medical community must prioritize patient quality of life in treatment decisions. Keywords: brain metastases, stereotactic radiosurgery, whole brain radiation therapy, quality of life, neurocognitive function, treatment evolution, cancer care","thumbnailUrl":null,"publishDate":"2017-03-14T00:00:00.000Z","doi":"10.4103/sni.sni_16_17","categories":["Neuro-oncology","Letter to the Editor"],"fullTextUrl":"http://surgicalneurologyint.com/wp-content/uploads/2017/03/8322/SNI-8-31.pdf"}